These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37260121)

  • 1. Platelet counts in
    Barton JC; Barton JC; Acton RT
    Platelets; 2023 Dec; 34(1):2217933. PubMed ID: 37260121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron overload phenotypes and HFE genotypes in white hemochromatosis and iron overload screening study participants without HFE p.C282Y/p.C282Y.
    Barton JC; Barton JC; Acton RT
    PLoS One; 2022; 17(7):e0271973. PubMed ID: 35895739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Height of non-Hispanic white adults with homeostatic iron regulator HFE genotypes p.C282Y/p.C282Y and wt/wt.
    Barton JC; Barton JC; Acton RT
    Mol Genet Genomic Med; 2024 Jan; 12(1):e2321. PubMed ID: 37930135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and characteristics of anti-HCV positivity and chronic hepatitis C virus infection in HFE p.C282Y homozygotes.
    Barton JC; Barton JC; Adams PC
    Ann Hepatol; 2019; 18(2):354-359. PubMed ID: 31056361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants and characteristics of mean corpuscular volume and hemoglobin concentration in white HFE C282Y homozygotes in the hemochromatosis and iron overload screening study.
    McLaren CE; Barton JC; Gordeuk VR; Wu L; Adams PC; Reboussin DM; Speechley M; Chang H; Acton RT; Harris EL; Ruggiero AM; Castro O;
    Am J Hematol; 2007 Oct; 82(10):898-905. PubMed ID: 17597476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemochromatosis and iron-overload screening in a racially diverse population.
    Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
    N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and genetic heterogeneity in hereditary haemochromatosis: association between lymphocyte counts and expression of iron overload.
    Porto G; Cardoso CS; Gordeuk V; Cruz E; Fraga J; Areias J; Oliveira JC; Bravo F; Gangaidzo IT; MacPhail AP; Gomo ZA; Moyo VM; Melo G; Silva C; Justiça B; de Sousa M
    Eur J Haematol; 2001 Aug; 67(2):110-8. PubMed ID: 11722599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HFE C282Y homozygotes aged 25-29 years at HEIRS Study initial screening.
    Barton JC; Acton RT; Leiendecker-Foster C; Lovato L; Adams PC; McLaren GD; Eckfeldt JH; McLaren CE; Reboussin DM; Gordeuk VR; Speechley MR; Reiss JA; Press RD; Dawkins FW;
    Genet Test; 2007; 11(3):269-75. PubMed ID: 17949288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic modifiers of penetrance to liver endpoints in HFE hemochromatosis: Associations in a large community cohort.
    Pilling LC; Atkins JL; Melzer D
    Hepatology; 2022 Dec; 76(6):1735-1745. PubMed ID: 35567766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in hepatic phenotype between hemochromatosis patients with HFE C282Y homozygosity and other HFE genotypes.
    Cheng R; Barton JC; Morrison ED; Phatak PD; Krawitt EL; Gordon SC; Kowdley KV
    J Clin Gastroenterol; 2009 Jul; 43(6):569-73. PubMed ID: 19359997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and penetrance of HFE mutations in 4865 unselected primary care patients.
    Phatak PD; Ryan DH; Cappuccio J; Oakes D; Braggins C; Provenzano K; Eberly S; Sham RL
    Blood Cells Mol Dis; 2002; 29(1):41-7. PubMed ID: 12482402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HFE C282Y homozygosity is associated with lower total and low-density lipoprotein cholesterol: The hemochromatosis and iron overload screening study.
    Adams PC; Pankow JS; Barton JC; Acton RT; Leiendecker-Foster C; McLaren GD; Speechley M; Eckfeldt JH
    Circ Cardiovasc Genet; 2009 Feb; 2(1):34-7. PubMed ID: 20031565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White blood cells and subtypes in HFE p.C282Y and wild-type homozygotes in the Hemochromatosis and Iron Overload Screening Study.
    Barton JC; Barton JC; Acton RT
    Blood Cells Mol Dis; 2017 Mar; 63():9-14. PubMed ID: 27915113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial screening transferrin saturation values, serum ferritin concentrations, and HFE genotypes in whites and blacks in the Hemochromatosis and Iron Overload Screening Study.
    Barton JC; Acton RT; Dawkins FW; Adams PC; Lovato L; Leiendecker-Foster C; McLaren CE; Reboussin DM; Speechley MR; Gordeuk VR; McLaren GD; Sholinsky P; Harris EL
    Genet Test; 2005; 9(3):231-41. PubMed ID: 16225403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical manifestations of hemochromatosis in HFE C282Y homozygotes identified by screening.
    McLaren GD; McLaren CE; Adams PC; Barton JC; Reboussin DM; Gordeuk VR; Acton RT; Harris EL; Speechley MR; Sholinsky P; Dawkins FW; Snively BM; Vogt TM; Eckfeldt JH;
    Can J Gastroenterol; 2008 Nov; 22(11):923-30. PubMed ID: 19018338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HFE Cys282Tyr homozygotes with serum ferritin concentrations below 1000 microg/L are at low risk of hemochromatosis.
    Allen KJ; Bertalli NA; Osborne NJ; Constantine CC; Delatycki MB; Nisselle AE; Nicoll AJ; Gertig DM; McLaren CE; Giles GG; Hopper JL; Anderson GJ; Olynyk JK; Powell LW; Gurrin LC;
    Hepatology; 2010 Sep; 52(3):925-33. PubMed ID: 20583211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HFE genotype and parameters of iron metabolism in German first-time blood donors - evidence for an increased transferrin saturation in C282Y heterozygotes.
    Raddatz D; Legler T; Lynen R; Addicks N; Ramadori G
    Z Gastroenterol; 2003 Nov; 41(11):1069-76. PubMed ID: 14648375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HFE mutations in Caucasian participants of the Hemochromatosis and Iron Overload Screening study with serum ferritin level <1000 µg/L.
    Adams PC; McLaren CE; Speechley M; McLaren GD; Barton JC; Eckfeldt JH
    Can J Gastroenterol; 2013 Jul; 27(7):390-2. PubMed ID: 23862168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships of serum ferritin, transferrin saturation, and HFE mutations and self-reported diabetes in the Hemochromatosis and Iron Overload Screening (HEIRS) study.
    Acton RT; Barton JC; Passmore LV; Adams PC; Speechley MR; Dawkins FW; Sholinsky P; Reboussin DM; McLaren GD; Harris EL; Bent TC; Vogt TM; Castro O
    Diabetes Care; 2006 Sep; 29(9):2084-9. PubMed ID: 16936157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron-overload-related disease in HFE hereditary hemochromatosis.
    Allen KJ; Gurrin LC; Constantine CC; Osborne NJ; Delatycki MB; Nicoll AJ; McLaren CE; Bahlo M; Nisselle AE; Vulpe CD; Anderson GJ; Southey MC; Giles GG; English DR; Hopper JL; Olynyk JK; Powell LW; Gertig DM
    N Engl J Med; 2008 Jan; 358(3):221-30. PubMed ID: 18199861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.